Ameriprise’s AbbVie ABBV Stock Holding History

Ameriprise’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-17,300	Closed	-$1.31M	–	3704
2019 Q3	$1.31M	Hold	17,300	–	–	﹤0.01%	2896
2019 Q2	$1.26M	Buy	+17,300	New	+$1.36M	﹤0.01%	2976
2016 Q1	–	Sell	-31,200	Closed	-$1.85M	–	3749
2015 Q4	$1.85M	Hold	31,200	–	–	﹤0.01%	2646
2015 Q3	$1.7M	Buy	+31,200	New	+$2.03M	﹤0.01%	2709

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise's ABBV Position: Q1 2026 in Review

Ameriprise increased its AbbVie (ABBV) stake by 10% in Q1 2026, buying an estimated $224M and bringing the position to 11,068,310 shares worth $2.41B. The position accounts for 0.56% of the portfolio, ranked #22.

Ameriprise first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.73B in Q3 2024. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Ameriprise held 11,068,310 shares of AbbVie worth $2.41B as of Q1 2026.
Ameriprise bought 1,007,672 AbbVie shares in Q1 2026, an estimated $224M.
AbbVie made up 0.56% of Ameriprise's portfolio in Q1 2026, its #22 holding.
Ameriprise first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Ameriprise's AbbVie position peaked at $2.73B in Q3 2024.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.